Posttranslational modification of p53: cooperative integrators of function.
暂无分享,去创建一个
[1] Karen H. Vousden,et al. Modifications of p53: competing for the lysines. , 2009, Current opinion in genetics & development.
[2] E. Appella,et al. Post-translational modifications and activation of p53 by genotoxic stresses. , 2001, European journal of biochemistry.
[3] W. Gu,et al. FBXO11 Promotes the Neddylation of p53 and Inhibits Its Transcriptional Activity* , 2007, Journal of Biological Chemistry.
[4] A. Strasser,et al. How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression? , 2007, Cell Death and Differentiation.
[5] A. Fersht,et al. Interaction between the Transactivation Domain of p53 and PC4 Exemplifies Acidic Activation Domains as Single-stranded DNA Mimics , 2009, The Journal of Biological Chemistry.
[6] K. Sakaguchi,et al. Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53 , 1992, Molecular and cellular biology.
[7] E. Appella,et al. SIGNALING TO THE P53 TUMOR SUPPRESSOR THROUGH PATHWAYS ACTIVATED BY GENOTOXIC AND NON-GENOTOXIC STRESSES. , 2002 .
[8] Xiongbin Lu,et al. The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop. , 2007, Cancer cell.
[9] Wei Gu,et al. p53 ubiquitination: Mdm2 and beyond. , 2006, Molecular cell.
[10] D. Lane,et al. Regulation of the specific DNA binding function of p53 , 1992, Cell.
[11] A. Wlodawer,et al. Two distinct motifs within the p53 transactivation domain bind to the Taz2 domain of p300 and are differentially affected by phosphorylation. , 2009, Biochemistry.
[12] C. Prives,et al. Blinded by the Light: The Growing Complexity of p53 , 2009, Cell.
[13] Jeffrey R. Marks,et al. Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23 , 2002, Nature Genetics.
[14] Wei Gu,et al. Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain , 1997, Cell.
[15] Shuo Lin,et al. p53 family in development , 2008, Mechanisms of Development.
[16] D. Meek,et al. Protein kinase CK1 is a p53‐threonine 18 kinase which requires prior phosphorylation of serine 15 , 1999, FEBS letters.
[17] D. Meek,et al. Mechanisms of switching on p53: a role for covalent modification? , 1999, Oncogene.
[18] D. Lane,et al. Differential regulation of p53 and p21 by MKRN1 E3 ligase controls cell cycle arrest and apoptosis , 2009, The EMBO journal.
[19] D. Livingston,et al. Polyubiquitination of p53 by a Ubiquitin Ligase Activity of p300 , 2003, Science.
[20] Yoichi Taya,et al. DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2 , 1997, Cell.
[21] J. Omichinski,et al. p53 and TFIIEα share a common binding site on the Tfb1/p62 subunit of TFIIH , 2008, Proceedings of the National Academy of Sciences.
[22] H. K. Sluss,et al. The ataxia telangiectasia-mutated target site Ser18 is required for p53-mediated tumor suppression. , 2007, Cancer research.
[23] W. Gu,et al. How does SIRT1 affect metabolism, senescence and cancer? , 2009, Nature Reviews Cancer.
[24] K. Sakaguchi,et al. Differential recognition of phosphorylated transactivation domains of p53 by different p300 domains. , 2008, Journal of molecular biology.
[25] E. Stavridi,et al. Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[26] Y. Miki,et al. DYRK2 is targeted to the nucleus and controls p53 via Ser46 phosphorylation in the apoptotic response to DNA damage. , 2007, Molecular cell.
[27] K. Yoshikawa,et al. Necdin Regulates p53 Acetylation via Sirtuin1 to Modulate DNA Damage Response in Cortical Neurons , 2008, The Journal of Neuroscience.
[28] H. Jane Dyson,et al. Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2 , 2009, Proceedings of the National Academy of Sciences.
[29] Jeffrey S. Smith. Human Sir2 and the 'silencing' of p53 activity. , 2002, Trends in cell biology.
[30] Wei Gu,et al. SnapShot: p53 Posttranslational Modifications , 2008, Cell.
[31] T. Iwakuma,et al. Crippling p53 activities via knock-in mutations in mouse models , 2007, Oncogene.
[32] S. Berger,et al. Repression of p53 activity by Smyd2-mediated methylation , 2006, Nature.
[33] D. Livingston,et al. p300/MDM2 complexes participate in MDM2-mediated p53 degradation. , 1998, Molecular cell.
[34] E. Seto,et al. The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men , 2008, Nature Reviews Molecular Cell Biology.
[35] K. Sakaguchi,et al. Phosphorylation of human p53 by p38 kinase coordinates N‐terminal phosphorylation and apoptosis in response to UV radiation , 1999, The EMBO journal.
[36] S. Di Giovanni,et al. The non‐apoptotic role of p53 in neuronal biology: enlightening the dark side of the moon , 2009, EMBO reports.
[37] K. Vousden,et al. p53-Ubl fusions as models of ubiquitination, sumoylation and neddylation of p53 , 2008, Cell cycle.
[38] Or Gozani,et al. Modulation of p53 function by SET8-mediated methylation at lysine 382. , 2007, Molecular cell.
[39] S. Sykes,et al. The ARF/Oncogene Pathway Activates p53 Acetylation within the DNA Binding Domain , 2007, Cell cycle.
[40] R. Carroll,et al. Mapping of phosphomonoester and apparent phosphodiester bonds of the oncogene product p53 from simian virus 40-transformed 3T3 cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[41] A. Burlingame,et al. Identification of New p53 Acetylation Sites in COS-1 Cells* , 2009, Molecular & Cellular Proteomics.
[42] A. Dejean,et al. The E3 SUMO ligase PIASy is a regulator of cellular senescence and apoptosis. , 2006, Molecular cell.
[43] Guillermina Lozano,et al. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53 , 1995, Nature.
[44] D. Lane,et al. Mdm2-Mediated NEDD8 Conjugation of p53 Inhibits Its Transcriptional Activity , 2004, Cell.
[45] D. Meek,et al. Serine 15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2 , 1999, The EMBO journal.
[46] D. Herr,et al. Ser18 and 23 phosphorylation is required for p53‐dependent apoptosis and tumor suppression , 2006, The EMBO journal.
[47] S. Sykes,et al. Acetylation of the DNA Binding Domain Regulates Transcription-independent Apoptosis by p53* , 2009, The Journal of Biological Chemistry.
[48] K. Sakaguchi,et al. Damage-mediated Phosphorylation of Human p53 Threonine 18 through a Cascade Mediated by a Casein 1-like Kinase , 2000, The Journal of Biological Chemistry.
[49] Ettore Appella,et al. ATM Mediates Phosphorylation at Multiple p53 Sites, Including Ser46, in Response to Ionizing Radiation* , 2002, The Journal of Biological Chemistry.
[50] Danny Reinberg,et al. Methylation-Acetylation Interplay Activates p53 in Response to DNA Damage , 2007, Molecular and Cellular Biology.
[51] Russell G. Jones,et al. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. , 2005, Molecular cell.
[52] D. Meek,et al. Critical roles for the serine 20, but not the serine 15, phosphorylation site and for the polyproline domain in regulating p53 turnover. , 2001, The Biochemical journal.
[53] A. Fersht,et al. Molecular mechanism of the interaction between MDM2 and p53. , 2002, Journal of molecular biology.
[54] E. Seto,et al. Acetylation and deacetylation of non-histone proteins. , 2005, Gene.
[55] A. Hengstermann,et al. Activation of p53 by conjugation to the ubiquitin‐like protein SUMO‐1 , 1999, The EMBO journal.
[56] Hong Lei,et al. Methylation of p53 by Set7/9 mediates p53 acetylation and activity in vivo. , 2008, Molecular cell.
[57] D. Livingston,et al. Binding and modulation of p53 by p300/CBP coactivators , 1997, Nature.
[58] Maria Miller,et al. Structural basis for p300 Taz2-p53 TAD1 binding and modulation by phosphorylation. , 2009, Structure.
[59] S. Berger,et al. Two tandem and independent sub-activation domains in the amino terminus of p53 require the adaptor complex for activity , 1997, Oncogene.
[60] Lee Baker,et al. Discovery, In Vivo Activity, and Mechanism of Action of a Small-Molecule p53 Activator , 2007, Cancer cell.
[61] G. Wahl,et al. Regulating the p53 pathway: in vitro hypotheses, in vivo veritas , 2006, Nature Reviews Cancer.
[62] T. Hupp,et al. The N-terminal Interferon-binding Domain (IBiD) Homology Domain of p300 Binds to Peptides with Homology to the p53 Transactivation Domain* , 2004, Journal of Biological Chemistry.
[63] Jill A. Livengood,et al. p53 Transcriptional Activity Is Mediated through the SRC1-interacting Domain of CBP/p300* , 2002, The Journal of Biological Chemistry.
[64] M. Fiscella,et al. Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[65] K. Gardner,et al. Recruitment of p300/CBP in p53-Dependent Signal Pathways , 1997, Cell.
[66] H. K. Sluss,et al. Phosphorylation of Serine 18 Regulates Distinct p53 Functions in Mice , 2004, Molecular and Cellular Biology.
[67] Reuven Agami,et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway , 2004, Nature.
[68] John Calvin Reed,et al. Regulation of p53 Localization and Activity by Ubc13 , 2006, Molecular and Cellular Biology.
[69] R. Hay,et al. Multiple C-Terminal Lysine Residues Target p53 for Ubiquitin-Proteasome-Mediated Degradation , 2000, Molecular and Cellular Biology.
[70] W. Gu,et al. Functional Analysis of the Roles of Posttranslational Modifications at the p53 C Terminus in Regulating p53 Stability and Activity , 2005, Molecular and Cellular Biology.
[71] Y. Sung,et al. Transactivation Ability of p53 Transcriptional Activation Domain Is Directly Related to the Binding Affinity to TATA-binding Protein (*) , 1995, The Journal of Biological Chemistry.
[72] F. Kashanchi,et al. Phosphorylation of p53 Serine 15 Increases Interaction with CBP* , 1998, The Journal of Biological Chemistry.
[73] Min Gyu Lee,et al. p53 is regulated by the lysine demethylase LSD1 , 2007, Nature.
[74] R. Hay,et al. SUMO‐1 modification activates the transcriptional response of p53 , 1999, The EMBO journal.
[75] J. Jenkins,et al. Cloning and expression analysis of full length mouse cDNA sequences encoding the transformation associated protein p53. , 1984, Nucleic acids research.
[76] Manuel Serrano,et al. p53: Guardian of the Genome and Policeman of the Oncogenes , 2007, Cell cycle.
[77] E. Appella,et al. Phosphorylation Site Interdependence of Human p53 Post-translational Modifications in Response to Stress* , 2003, Journal of Biological Chemistry.
[78] A. Fersht,et al. Four domains of p300 each bind tightly to a sequence spanning both transactivation subdomains of p53 , 2007, Proceedings of the National Academy of Sciences.
[79] D. Lane,et al. p53, guardian of the genome , 1992, Nature.
[80] H. Sheppard,et al. Phosphorylation on Thr-55 by TAF1 mediates degradation of p53: a role for TAF1 in cell G1 progression. , 2004, Molecular cell.
[81] K. Sakaguchi,et al. DNA damage activates p53 through a phosphorylation-acetylation cascade. , 1998, Genes & development.
[82] G. Wahl,et al. The C-terminal lysines fine-tune P53 stress responses in a mouse model but are not required for stability control or transactivation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[83] Yi Tang,et al. Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. , 2006, Molecular cell.
[84] J. Espinosa,et al. Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment. , 2001, Molecular cell.
[85] K. Sakaguchi,et al. SMAR1 forms a ternary complex with p53-MDM2 and negatively regulates p53-mediated transcription. , 2009, Journal of molecular biology.
[86] S. Durell,et al. The Wip1 phosphatase PPM1D dephosphorylates SQ/TQ motifs in checkpoint substrates phosphorylated by PI3K-like kinases. , 2007, Biochemistry.
[87] A. Thompson,et al. Dephosphorylation of p53 at Ser20 after cellular exposure to low levels of non-ionizing radiation , 1999, Oncogene.
[88] A. Aranda-Anzaldo,et al. Reassessing the role of p53 in cancer and ageing from an evolutionary perspective , 2007, Mechanisms of Ageing and Development.
[89] T. Unger,et al. Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2 , 1999, The EMBO journal.
[90] S. Lowe,et al. E1A signaling to p53 involves the p19(ARF) tumor suppressor. , 1998, Genes & development.
[91] G. Evan,et al. Mdm2 is critically and continuously required to suppress lethal p53 activity in vivo. , 2006, Cancer cell.
[92] G. Kroemer,et al. Essential role of p53 phosphorylation by p38 MAPK in apoptosis induction by the HIV-1 envelope , 2005, The Journal of experimental medicine.
[93] T. Jacks,et al. Defective apoptosis and B‐cell lymphomas in mice with p53 point mutation at Ser 23 , 2004, The EMBO journal.
[94] S. Müller,et al. Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[95] Yolanda F. Darlington,et al. The type 2C phosphatase Wip1: An oncogenic regulator of tumor suppressor and DNA damage response pathways , 2008, Cancer and Metastasis Reviews.
[96] H. Giebler,et al. Binding of p53 to the KIX Domain of CREB Binding Protein , 1999, The Journal of Biological Chemistry.
[97] T. Hofmann,et al. PML is required for homeodomain-interacting protein kinase 2 (HIPK2)-mediated p53 phosphorylation and cell cycle arrest but is dispensable for the formation of HIPK domains. , 2003, Cancer research.
[98] Yi Tang,et al. Acetylation Is Indispensable for p53 Activation , 2008, Cell.
[99] Stefano Piccolo,et al. Integration of TGF-ß and Ras/MAPK Signaling Through p53 Phosphorylation , 2007, Science.
[100] Albert J. Fornace,et al. Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase , 2006, The Journal of experimental medicine.
[101] T. Jacks,et al. Lack of p53 Ser389 phosphorylation predisposes mice to develop 2-acetylaminofluorene-induced bladder tumors but not ionizing radiation-induced lymphomas. , 2005, Cancer research.
[102] Yolande F M Ramos,et al. Comparative study of the p53-mdm2 and p53-MDMX interfaces , 1999, Oncogene.
[103] Wei Gu,et al. Modes of p53 Regulation , 2009, Cell.
[104] K. Sakaguchi,et al. Human p53 Is Phosphorylated on Serines 6 and 9 in Response to DNA Damage-inducing Agents* , 2000, The Journal of Biological Chemistry.
[105] X Chen,et al. Protein methylation: a new mechanism of p53 tumor suppressor regulation. , 2008, Histology and histopathology.
[106] T. Hupp,et al. The Proline Repeat Domain of p53 Binds Directly to the Transcriptional Coactivator p300 and Allosterically Controls DNA-Dependent Acetylation of p53 , 2003, Molecular and Cellular Biology.
[107] Yan-Hsiung Wang,et al. Identification and Characterization of a Novel p300-mediated p53 Acetylation Site, Lysine 305* , 2003, Journal of Biological Chemistry.
[108] Albert J. Fornace,et al. Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity , 2002, Nature Genetics.
[109] T. Hofmann,et al. Homeodomain-interacting protein kinase 2 is the ionizing radiation-activated p53 serine 46 kinase and is regulated by ATM. , 2007, Cancer research.
[110] Antonio Rosato,et al. A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasis , 2009, Cell.
[111] G. Wahl,et al. Mouse Mutants Reveal that Putative Protein Interaction Sites in the p53 Proline-Rich Domain Are Dispensable for Tumor Suppression , 2006, Molecular and Cellular Biology.
[112] Wei Gu,et al. Synergistic activation of transcription by CBP and p53 , 1997, Nature.
[113] Muyang Li,et al. Acetylation of p53 Inhibits Its Ubiquitination by Mdm2* , 2002, The Journal of Biological Chemistry.
[114] U. Knippschild,et al. p53 is phosphorylated in vitro and in vivo by the delta and epsilon isoforms of casein kinase 1 and enhances the level of casein kinase 1 delta in response to topoisomerase-directed drugs , 1997, Oncogene.
[115] C. Maki,et al. Regulation of p53 Nuclear Export through Sequential Changes in Conformation and Ubiquitination* , 2007, Journal of Biological Chemistry.
[116] Lawrence A. Donehower,et al. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53 , 1995, Nature.
[117] T. Hupp,et al. Inhibition of p53‐dependent transcription by BOX‐I phospho‐peptide mimetics that bind to p300 , 2001, EMBO reports.
[118] M. Jansson,et al. Arginine methylation regulates the p53 response , 2008, Nature Cell Biology.
[119] E. Appella,et al. Wip1 phosphatase modulates ATM-dependent signaling pathways. , 2006, Molecular cell.
[120] Yoshiharu Kawaguchi,et al. MDM2–HDAC1‐mediated deacetylation of p53 is required for its degradation , 2002, The EMBO journal.
[121] Ettore Appella,et al. p300/CBP‐mediated p53 acetylation is commonly induced by p53‐activating agents and inhibited by MDM2 , 2001, The EMBO journal.
[122] Muyang Li,et al. Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2 , 2003, Science.
[123] Giulia Piaggio,et al. Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis , 2002, Nature Cell Biology.
[124] T. Jacks,et al. Increased Sensitivity to UV Radiation in Mice with a p53 Point Mutation at Ser389 , 2004, Molecular and Cellular Biology.
[125] D. Meek,et al. Phosphorylation of p53 in normal and simian virus 40-transformed NIH 3T3 cells , 1988, Molecular and cellular biology.
[126] S. Weger,et al. Topors acts as a SUMO‐1 E3 ligase for p53 in vitro and in vivo , 2005, FEBS letters.
[127] Yoichi Taya,et al. Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2 , 2002, Nature Cell Biology.
[128] H. Dyson,et al. Mapping the interactions of the p53 transactivation domain with the KIX domain of CBP. , 2009, Biochemistry.
[129] S. Berger,et al. p53 Sites Acetylated In Vitro by PCAF and p300 Are Acetylated In Vivo in Response to DNA Damage , 1999, Molecular and Cellular Biology.
[130] Ronen Marmorstein,et al. Acetylation of the p53 DNA-binding domain regulates apoptosis induction. , 2006, Molecular cell.
[131] D. Meek. Tumour suppression by p53: a role for the DNA damage response? , 2009, Nature Reviews Cancer.
[132] B. Vogelstein,et al. Participation of p53 protein in the cellular response to DNA damage. , 1991, Cancer research.
[133] E. Dennis,et al. Handbook of cell signaling , 2004 .
[134] Masaaki Adachi,et al. p53‐inducible Wip1 phosphatase mediates a negative feedback regulation of p38 MAPK‐p53 signaling in response to UV radiation , 2000, The EMBO journal.
[135] A. Fersht,et al. Regulation by phosphorylation of the relative affinities of the N-terminal transactivation domains of p53 for p300 domains and Mdm2 , 2009, Oncogene.
[136] Toshiaki Hara,et al. Structure of the Tfb1/p53 complex: Insights into the interaction between the p62/Tfb1 subunit of TFIIH and the activation domain of p53. , 2006, Molecular cell.
[137] H. Yasuda,et al. Involvement of PIAS1 in the sumoylation of tumor suppressor p53. , 2001, Molecular cell.
[138] J. Qin,et al. Trim24 targets endogenous p53 for degradation , 2009, Proceedings of the National Academy of Sciences.
[139] Michael A. Dyer,et al. MDMX: from bench to bedside , 2007, Journal of Cell Science.
[140] Zigang Dong,et al. Post-translational modification of p53 in tumorigenesis , 2004, Nature Reviews Cancer.